Stay updated on Gilead Sciences Press Releases

Sign up to get notified when there's something new on the Gilead Sciences Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Gilead Sciences Press Releases page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    Important update:The recent update on the webpage highlights Gilead's announcement of a funding initiative aimed at supporting HIV prevention, anti-stigma, and health equity efforts specifically for Black cisgender and transgender women and girls in the U.S. This change signifies a significant commitment by Gilead towards addressing important health disparities and promoting inclusivity within these communities.
    Difference
    3%
    Check dated 2024-02-28T07:42:29.000Z thumbnail image
  5. Check
    5 days ago
    Change Detected
    Summary
    Important update:The recent update on the webpage indicates that the U.S. FDA has approved an expanded indication for Gilead’s Biktarvy® to treat individuals with HIV who have suppressed viral loads and pre-existing resistance. Additionally, Gilead will be presenting late-breaking data and real-world evidence showcasing their innovative antiviral portfolio and research pipeline at CROI 2024.
    Difference
    6%
    Check dated 2024-02-27T06:46:20.000Z thumbnail image
  6. Check
    11 days ago
    Change Detected
    Summary
    Important update:The recent update on the webpage indicates that Gilead Sciences will be presenting at upcoming investor conferences on February 20, 2024. This change likely signifies an important announcement or event related to the company's financial performance and strategic direction.
    Difference
    1%
    Check dated 2024-02-20T23:39:04.000Z thumbnail image
  7. Check
    20 days ago
    Change Detected
    Summary
    Important update:The value that has recently changed on the webpage is the announcement that Gilead Sciences has expanded its liver portfolio through the acquisition of CymaBay Therapeutics on February 12, 2024. This represents a significant development in Gilead's efforts to enhance its offerings in the field of liver-related therapeutics.
    Difference
    2%
    Check dated 2024-02-12T14:25:29.000Z thumbnail image
  8. Check
    22 days ago
    Change Detected
    Summary
    Important update:The value on the webpage has recently changed to "February 09, 2024 Gilead Named One of America’s Most JUST Companies by JUST Capital and CNBC." This change represents an announcement that Gilead has been recognized as one of America's most just companies by JUST Capital and CNBC.
    Difference
    2%
    Check dated 2024-02-10T12:38:51.000Z thumbnail image
  9. Check
    24 days ago
    Change Detected
    Summary
    Important update:The value "Access our fourth quarter and full year 2023 results" on the webpage has recently changed to an empty value. This change represents that the access to the financial results for the fourth quarter and full year of 2023 is no longer available on the webpage.
    Difference
    2%
    Check dated 2024-02-08T11:01:09.000Z thumbnail image

Stay in the know with updates to Gilead Sciences Press Releases

Enter your email address, and we'll notify you when there's something new on the Gilead Sciences Press Releases page.